Events Calendar

The Virtual Investors' Conference on Biotech ABS

IMN’s Virtual Investors’ Conference on Biotech ABS, taking place November 18, will provide a platform to understand the biotech and healthcare sector, helping educate investors, borrowers and industry participants on the hottest new asset class in equity capital markets. This one-day virtual conference will consist of morning sessions focused on European aspects, and afternoon panels with a focus on the U.S., as regulatory challenges will be forefront on both sides of the globe. 

Biotech issuance in 2020 has now surpassed $60 billion globally, spurring this asset class to become the second most popular equity capital markets sector, with momentum driven by huge secondary moves and companies benefitting from a greater focus on healthcare investing that Covid-19 has generated.  

Join this must-attend gathering to engage with hedge funds, institutional investors, and more, to discover exciting new investment opportunities as this sector expands to comply with policy, market demand and changing consumer needs.



Biotech Banner

Location Virtual